Tony Thompson - Aug 5, 2022 Form 3 Insider Report for EAGLE MATERIALS INC (EXP)

Role
Senior Vice President
Signature
/s/ Scott M. Wilson as Attorney-in-Fact for Tony Thompson
Stock symbol
EXP
Transactions as of
Aug 5, 2022
Transactions value $
$0
Form type
3
Date filed
8/15/2022, 05:22 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXP Common Stock 12.9K Aug 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 890 $106.24 Direct F2
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 826 $106.24 Direct F3
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 3.26K $91.58 Direct F4
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 3.08K $91.58 Direct F5
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 3.06K $60.21 Direct F6
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 2.55K $60.21 Direct F7
holding EXP Non-Qualified Stock Option (Right to Buy) Aug 5, 2022 Common Stock 1.16K $126.22 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number includes the following restricted shares: (a) 631 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 3,083 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,666 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 1,337 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026.
F2 On May 17, 2018, the reporting person was granted an option to purchase up to 3,969 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,561 shares, 890 of which remain exercisable.
F3 On May 17, 2018 the reporting person was granted an option to purchase up to 3,307 shares of Common Stock, and currently 826 of these options remain exercisable.
F4 On May 16, 2019, the reporting person was granted an option to purchase up to 4,933 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 4,324 shares. Currently 2,171 options are exercisable and the remaining options vest on March 31, 2023.
F5 On May 16, 2019 the reporting person was granted an option to purchase up to 4,111 shares of Common Stock. Currently 2,056 options are exercisable and the remaining options will vest on March 31, 2023.
F6 On May 19, 2020, the reporting person was granted an option to purchase up to 3,057 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 3,057 shares. Currently 1,529 options are exercisable and the remaining options vest on March 31 of 2023 and 2024.
F7 On May 19, 2020 the reporting person was granted an option to purchase up to 2,548 shares of Common Stock. Currently 1,274 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024.
F8 On May 19, 2022 the reporting person was granted an option to purchase up to 1,159 shares of Common Stock, which will vest ratably on March 31 of 2023, 2024, 2025 and 2026.